BMT CTN Protocol 0403

A Phase III, Randomized Double-Blind, Placebo Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation

Below are protocol-related doucments, which may be periodically updated.

BMT CTN Protocol #0403 closed new patient accrual on September 14, 2011.